glp-1 wegovy GLP-1s work but when they're stopped, the effects stop too: Expert GLP-1 nonresponders: Up to 1

10 People with a history of SCC also have an increased risk of developing malignant melanoma

Purpose-built for physicians Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology

However, in excess, it can cause oxidative damage to lipids, proteins, and DNA, contributing to aging, inflammation, and diseases such as cancer and neurodegenerative disorders

10x in advance

This aligns with major trends in healthcare, where patients and providers alike are looking for safer, more natural treatment options